Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells

Molecular Pharmacology

Volumn 80, Issue 1, 2011, Pages 191-200

  Li, Jiang ^a   Zhang, Yifei ^a   Kuruba, Ramalinga ^a   Gao, Xiang ^a   Gandhi, Chandrashekhar R ^b   Xie, Wen ^a   Li, Song ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; FARNESOID X RECEPTOR; MESSENGER RNA; MICRORNA; MICRORNA 29A; SCLEROPROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL; UPREGULATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 79959305674     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.068247     Document Type: Article

References (43)

1. Bertolotti M, Gabbi C, Anzivino C, Carulli L, Loria P, and Carulli N (2008) Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: insights from evidence on hepatic cholesterol degradation and gallstone disease in humans. Curr Med Chem 15:2271-2284.
2. Chiang JY (2002) Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 23:443-463.
3. Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, Fruchart JC, Dallongeville J, Hum DW, Kuipers F, et al. (2002) Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest 109:961-971. (Pubitemid 34275117)
4. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, and Lu J (2010) Mir-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol doi:10.1165/rcmb.2010-0323OC.
5. Dong H, Paquette M, Williams A, Zoeller RT, Wade M, and Yauk C (2010) Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs. PLoS One 5:e12136.
6. Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld AM, Edwards PA, et al. (2003) A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell 11:1079-1092. (Pubitemid 36566328)
7. Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pellicciari R, and Morelli A (2004) The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 127:1497-1512. (Pubitemid 39457775)
8. Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Morelli A, Pruzanski M, and Pellicciari R (2005a) Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. J Pharmacol Exp Ther 315:58-68. (Pubitemid 41380498)
9. Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pruzanski M, Morelli A, and Pellicciari R (2005b) A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J Pharmacol Exp Ther 314:584-595. (Pubitemid 41043838)
10. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, et al. (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687-693.
11. Forman JJ, Legesse-Miller A, and Coller HA (2008) A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci USA 105:14879-14884.
12. Friedman SL (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88:125-172.
13. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, Ridolfi F, Trozzi L, Surrenti C, and Casini A (2002) Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 122:1924-1940. (Pubitemid 34651436)
14. Ghildiyal M and Zamore PD (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10:94-108.
15. Guo CJ, Pan Q, Li DG, Sun H, and Liu BW (2009) miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol 50:766-778.
16. Han YC, Park CY, Bhagat G, Zhang J, Wang Y, Fan JB, Liu M, Zou Y, Weissman IL, and Gu H (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 207:475-489.
17. He F, Li J, Mu Y, Kuruba R, Ma Z, Wilson A, Alber S, Jiang Y, Stevens T, Watkins S, et al. (2006) Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ Res 98:192-199.
18. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
19. Ji J, Zhang J, Huang G, Qian J, Wang X, and Mei S (2009) Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583:759-766.
20. Jiang X, Tsitsiou E, Herrick SE, and Lindsay MA (2010) MicroRNAs and the regulation of fibrosis. FEBS J 277:2015-2021.
21. Jiao J, Friedman SL, and Aloman C (2009) Hepatic fibrosis. Current Opinion in Gastroenterology 25:223-229.
22. Kapinas K, Kessler C, Ricks T, Gronowicz G, and Delany AM (2010) miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285:25221-25231.
23. Kwiecinski M, Strack I, Noetel A, Schievenbusch S, Scheffler M, Elfimova N, Dienes HP, and Odenthal M (2009) MicroRNA-29: a novel antifibrogenic mediator in liver fibrogenesis. J Hepatol 50 (Suppl 1):S110.
24. Laffitte BA, Kast HR, Nguyen CM, Zavacki AM, Moore DD, and Edwards PA (2000) Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J Biol Chem 275:10638-10647. (Pubitemid 30202131)
25. Lee RC, Feinbaum RL, and Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854. (Pubitemid 24014542)
26. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, and Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787-798. (Pubitemid 38058492)
27. Li J, Wilson A, Gao X, Kuruba R, Liu Y, Poloyac S, Pitt B, Xie W, and Li S (2009) Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. J Pharmacol Exp Ther 331:234-243.
28. Li J, Wilson A, Kuruba R, Zhang Q, Gao X, He F, Zhang LM, Pitt BR, Xie W, and Li S (2008) FXR-mediated regulation of eNOS expression in vascular endothelial cells. Cardiovasc Res 77:169-177. (Pubitemid 351195146)
29. Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, Creech KL, Moore LB, Wilson JG, Lewis MC, et al. (2000) Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 43:2971-2974. (Pubitemid 30626755)
30. Marek CJ, Tucker SJ, Konstantinou DK, Elrick LJ, Haefner D, Sigalas C, Murray GI, Goodwin B, and Wright MC (2005) Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXRindependent mechanisms. Biochem J 387:601-608. (Pubitemid 40685693)
31. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, Anania FA, Willson TM, and Tsukamoto H (2000) Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem 275:35715-35722.
32. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, and Rana TM (2009) Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 34:696-709.
33. Parsons CJ, Takashima M, and Rippe RA (2007) Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 22:S79-S84. (Pubitemid 46848998)
34. Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, and Beland FA (2010) Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 90:1437-1446.
35. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, et al. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53:209-218.
36. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, and Gonzalez FJ (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102:731-744.
37. Thirunavukkarasu C, Uemura T, Wang LF, Watkins SC, and Gandhi CR (2005) Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes. J Cell Physiol 204:654-665. (Pubitemid 40934662)
38. Umesono K, Murakami KK, Thompson CC, and Evans RM (1991) Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255-1266. (Pubitemid 121001338)
39. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, and Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105:13027-13032.
40. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, and Zern MA (2010) Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 298:G101-G106.
41. Xin F, Li M, Balch C, Thomson M, Fan M, Liu Y, Hammond SM, Kim S, and Nephew KP (2009) Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics 25:430-434.
42. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, Mukherjee P, Friedman SL, and Eng FJ (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54:142-151. (Pubitemid 40007234)
43. Zhang Y, Hagedorn CH, and Wang L (2010) Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta doi:10.1016/j.bbadis.2010.10.006.